Pharmaceutical

In people with diabetes and obesity, orforglipron led to weight loss near what people without diabetes experienced in prior testing.

Eli Lilly and Company has announced that Anne White, executive vice president and president of Lilly Neuroscience, will retire at the end of 2025 afte...

Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial for primary immune thrombocytopenia (ITP), a rare a...

BeOne Medicines is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra for up to $950 million.

The U.S. drug regulator has unveiled a plan to dramatically speed up adverse event reporting.

Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the...

The company touts a large U.S. market opportunity for scPharmaceuticals’ Furoscix, which recently expanded into chronic kidney disease.

On Monday, Argenx reported that its chief drug Vyvgart met the mark in a phase 3 trial assessing the FcRn blocker in the subset of generalized myasthe...

Biopharmaceutical firms in the U.S. and Europe are turning to China’s biotech sector for new medicines, with licensing hitting a record pace in 2025....

The asset deal thrusts AbbVie to the forefront of the psychedelic field, handing it a therapy that recently scored positive Phase 2 results in major d...